Immunologic approaches for the treatment of multiple myeloma.
about
CS1 (SLAMF7, CD319) is an effective immunotherapeutic target for multiple myeloma.Endoplasmic reticulum stress in the development of multiple myeloma and drug resistance.Enumeration, functional responses and cytotoxic capacity of MAIT cells in newly diagnosed and relapsed multiple myeloma.[Multiple myeloma : What has been confirmed in therapy?]
P2860
Immunologic approaches for the treatment of multiple myeloma.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Immunologic approaches for the treatment of multiple myeloma.
@en
type
label
Immunologic approaches for the treatment of multiple myeloma.
@en
prefLabel
Immunologic approaches for the treatment of multiple myeloma.
@en
P2093
P2860
P1476
Immunologic approaches for the treatment of multiple myeloma.
@en
P2093
Faith E Davies
Gareth J Morgan
Leo Rasche
Niels Weinhold
P2860
P304
P356
10.1016/J.CTRV.2017.03.010
P577
2017-04-06T00:00:00Z